Last reviewed · How we verify

NCT06120010

Prevalence of Anatomical Variants of Dural Sinuses by MRV Evaluation in Sohag

Status unknown Last updated 7 November 2023
What this trial tests

trial testing MRI in Anatomical Variants of Dural Sinuses by MRV in 169 participants. Status unknown.

Timeline
30 September 2023
Primary endpoint
30 June 2024
30 June 2024

Quick facts

Lead sponsorSohag University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment169
Start date30 September 2023
Primary completion30 June 2024
Estimated completion30 June 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Sohag University

Who can join

Eligibility, female only, with Anatomical Variants of Dural Sinuses by MRV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to use the MRV to depict the prevalence of anatomical variants of dural venous sinuses in Sohag population, which can help to avoid potenital pitfalls in the diagnosis of dural venous sinus thrombosis, venous infarcts and venous hemorrhage.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06120010.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing